News for Healthier Living
Xylyx Bio awarded $2.45M NIH SBIR grant from NIDDK to facilitate development of effective drugs for fibrotic liver disease
Award supports the development of a cell-based assay platform to help scientists discover and test drug candidates for liver fibrosis.
September 16, 2024
September 16 2024September 15 2024September 14 2024September 13 2024September 12 2024September 11 2024September 10 2024September 9 2024September 8 2024September 7 2024September 6 2024September 5 2024September 4 2024September 3 2024
|
|
|
|
|